The tumor inflammation signature (TIS) is associated with anti-PD-1 treatment benefit in the CERTIM pan-cancer cohort
暂无分享，去创建一个
T. Creasy | S. Warren | K. Leroy | F. Goldwasser | C. Tlemsani | C. Gervais | M. Alifano | D. Damotte | A. Cesano | R. Herbst | F. Letourneur | S. Warren | J. Biton | Hanane Ouakrim | A. Bellesoeur | P. Boudou-Rouquette | B. Burroni | X. Ren | N. Kramkimel | Angéline Duché | J. Arrondeau | A. Mansuet-Lupo | R. Halpin | Han Si | P. Morel | Han Si